Breaking News
- PhRMA Report: More than 500 medicines in development to treat disorders of the blood
- Singapore based Healthcare Company Receives Coveted WHO certification for its Vaccine Data Logger
- Prospect Medical Holdings Announces Partnership with Angeles-IPA
- Nouscom Announces Janssen Receives US FDA IND Clearance for VAC85135, an ‘Off-The-Shelf’ Cancer Immunotherapy Developed using Nouscom’s Proprietary Viral Vector Platform
- Emmes Supports Landmark mRNA COVID-19 Vaccine Trial in Sub-Saharan Africa
Recent Added
-
Health
PhRMA Report: More than 500 medicines in development to treat disorders of the blood
Spread the lovePhRMA Today, the Pharmaceutical Research and Manufacturers of America released a new report covering 549 medicines in development to potentially…
Read More » -
Health
Singapore based Healthcare Company Receives Coveted WHO certification for its Vaccine Data Logger
Spread the loveWHO certification for its Vaccine Data Logger The WHO PQS certification is a rigorous process of prequalifying products…
Read More » -
Health
Prospect Medical Holdings Announces Partnership with Angeles-IPA
Spread the loveProspect Medical Prospect Medical Holdings (PMH) has announced a partnership with Angeles-IPA, A Medical Corporation (AIPA), to expand the…
Read More » -
Health
Nouscom Announces Janssen Receives US FDA IND Clearance for VAC85135, an ‘Off-The-Shelf’ Cancer Immunotherapy Developed using Nouscom’s Proprietary Viral Vector Platform
Spread the loveVAC85135 is a novel clinical candidate developed by Nouscom and Janssen under a multi-project agreement Nouscom Nouscom, a…
Read More »
